Skip to main content
SpringerLink
Log in

Rapid Hepatitis B Immunisation for the Traveller

Comparison of Two Accelerated Schedules with a 2-Month Schedule

  • Short Communication
  • Published:
BioDrugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Table I

Notes

  1. The use of tradenames is for product identification purposes only, and does not imply endorsement.

References

  1. Bock HL, Löscher T, Scheiermann N, et al. Accelerated schedule for hepatitis B immunization. J Travel Med 1995; 2: 213–7

    Article  PubMed  Google Scholar 

  2. Anonymous. Hepatitis B targets endorsed by the World Health Assembly. Perspectives (Montclair) 1992; 3: 1-2

  3. Zuckerman J, Steffen R. Risks of hepatitis B in travelers as compared to immunization status. J Travel Med 2000; 7: 170–4

    Article  PubMed  CAS  Google Scholar 

  4. Zuckerman J. Travel-related hepatitis A & B. Travel Med Pract 1999; 1: 6–8

    Google Scholar 

  5. World Health Organization. International travel and health. Geneva, Switzerland: World Health Organization, 2002

    Google Scholar 

  6. Lockie C, Walker E, Calvert L, et al., editors. Travel medicine and migrant health. Edinburgh: Churchill Livingstone, 2000

    Google Scholar 

  7. Jong E. Risks of hepatitis A and B in the traveling public. J Travel Med 2001; 8Suppl. l: S3–8

    Article  PubMed  Google Scholar 

  8. Hawkes S, Hart GJ, Johnson AM, et al. Risk behaviour and HIV prevalence in international travellers. AIDS 1994; 8: 247–52

    Article  PubMed  CAS  Google Scholar 

  9. Rogers HL, Reilly SM. A survey of the health experiences of international business travelers: Part One -Physiological aspects. AAOHN J 2002; 50: 449–59

    PubMed  Google Scholar 

  10. Mulhall BP, Hu M, Thompson M, et al. Planned sexual behaviour of young Australian visitors to Thailand. Med J Aust 1993; 158: 530–5

    PubMed  CAS  Google Scholar 

  11. Correia JD, Shafer RT, Patel V, et al. Blood and body fluid exposure as a health risk for international travelers. J Travel Med 2001; 8: 263–6

    Article  PubMed  CAS  Google Scholar 

  12. Steffen R. Travel medicine: prevention based on epidemiological data. Trans R Soc Trop Med Hyg 1991; 85: 156–62

    Article  PubMed  CAS  Google Scholar 

  13. Rustgi VK, Schleupner CJ, Krause DS. Comparative study of the immunogenicity and safety of Engerix-B administered at 0,1, 2 and 12 months and Recombivax HB administered at 0, 1, and 6 months in healthy adults. Vaccine 1995; 13: 1665–8

    Article  PubMed  CAS  Google Scholar 

  14. Marsano LS, Greenberg RN, Kirkpatrick RB, et al. Comparison of a rapid hepatitis B immunization schedule to the standard schedule for adults. Am J Gas-troenterol 1996;91: 111–5

    CAS  Google Scholar 

  15. Van Damme P, Cramm M, Van Gompel A, et al. Analysis of travelers profile in Belgium [abstract 371]. Proceedings of the Third Conference on International Travel Medicine; 1993 Apr 26–29; Paris, France: 267

  16. Wahl M, Hermodsson S, Iwarson S. Hepatitis B vaccination with short dose intervals: a possible alternative for post-exposure prophylaxis? Infection 1988; 16: 229–32

    Article  PubMed  CAS  Google Scholar 

  17. Nothdurft HD, Dietrich M, Zuckerman JN, et al. A new accelerated vaccination schedule for rapid protection against hepatitis A and B. Vaccine 2002; 20:1157–62

    Article  PubMed  CAS  Google Scholar 

  18. Marchou B, Excler JL, Bourderioux C, et al. A 3-week hepatitis B vaccination schedule provides rapid and persistent protective immunity: a multicenter, randomized trial comparing accelerated and classic vaccination schedules. J Infect Dis 1995; 172: 258–60

    Article  PubMed  CAS  Google Scholar 

  19. Marchou B, Picot N, Chavanet P, et al. Three-week hepatitis B vaccination provides protective immunity. Vaccine 1993; 11: 1383–5

    Article  PubMed  CAS  Google Scholar 

  20. Harries AD, Clark M, Beeching NJ, et al. Early anti-HBs antibody response to accelerated and to conventional hepatitis B vaccination regimens in healthy persons. J Infect 1991; 23: 251–4

    Article  PubMed  CAS  Google Scholar 

  21. Belloni C, Pistorio A, Tinelli C, et al. Early immunisation with hepatitis B vaccine: a five-year study. Vaccine 2000; 18: 1307–11

    Article  PubMed  CAS  Google Scholar 

  22. Asencio J, Ramirez-Ronda CH, Febo C. Comparative study of two immunization regimes for health care workers (HCW) using the hepatitis B vaccine [abstract H76]. 36th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); 1996 Sep 15–18; New Orleans: 176

  23. Wright NM, Campbell TL, Tompkins CN. Comparison of conventional and accelerated hepatitis B immunisation schedules for homeless drug users. Commun Dis Public Health 2002; 5: 324–6

    PubMed  CAS  Google Scholar 

  24. Banatvala J, Van Damme P, Oehen S. Lifelong protection against hepatitis B: the role of vaccine immunogenicity in immune memory. Vaccine 2000; 19: 877–85

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

No funding was provided for the preparation of this manuscript. The author has provided no information on conflicts of interest directly relevant to the content of this short commuication.

Author information

Authors and Affiliations

  1. GlaxoSmithKline Biologicals, Singapore

    Hans L. Bock

Authors
  1. Hans L. Bock
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hans L. Bock.

Additional information

The study data in this Short Communication have been presented in full in J Travel Med 1995; 2: 213-7. [1] The discussion has been updated. This article is published with permission

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bock, H.L. Rapid Hepatitis B Immunisation for the Traveller. BioDrugs 17 (Suppl 1), 11–13 (2003). https://doi.org/10.2165/00063030-200317001-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00063030-200317001-00003

Keywords

Search

Navigation